Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Phase I first-in-human dose-escalation trial of a bladder cancer-specific nanoparticle in non-muscle-invasive bladder cancer.
Nanomedicine (London, England)·2026
Same author
Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer.
Biomedicines·2026
Same author
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate Cancer.
Molecular cancer therapeutics·2026


